{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:25:37Z","timestamp":1785475537364,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T00:00:00Z","timestamp":1698451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T00:00:00Z","timestamp":1698451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We aimed to investigate the clinico-radiologic features of acute Marchiafava-Bignami disease (MBD) and its evolutionary process after effective treatment through subgroup comparison. The clinical and MRI data of 23 patients with acute MBD were retrospectively analyzed and divided into type A (12 cases, with entire callosal involvement) and type B (11 cases, with focal callosal involvement). The clinical assessments and MRI findings (before and after treatment) were compared between the two subtypes. Compared with type B, type A had lower MoCA (Montreal Cognitive Assessment) scores at admission (16.50\u2009\u00b1\u20091.73 vs 18.27\u2009\u00b1\u20091.68, P\u2009=\u20090.021) and were more common with extracallosal involvement (66.67% vs 18.18%, P\u2009=\u20090.036) and longer illness duration (18.3\u2009\u00b1\u20092.1\u00a0days vs 15.6\u2009\u00b1\u20092.4\u00a0days, P\u2009=\u20090.012). During the treatment, the residual lesion in the splenium was more common in type A (58.33% vs 9.09%, P\u2009=\u20090.027). After treatment, the MoCa scores of both subtypes gradually increased (P\u2009&lt;\u20090.001), and the callosal and extracallasal lesions disappeared completely. Clinico-radiologic typing of acute MBD is related to the severity of early symptoms, but not to the prognosis. Complete clinico-radiologic recovery is possible for both subtypes with combined treatment. The clinico-radiologic reversibility is helpful for accurate diagnosis and therapeutic evaluation.<\/jats:p>","DOI":"10.1038\/s41598-023-45431-6","type":"journal-article","created":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T13:01:31Z","timestamp":1698498091000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinico-radiologic subtypes and therapeutic observation of acute Marchiafava-Bignami disease"],"prefix":"10.1038","volume":"13","author":[{"given":"Yan-li","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,28]]},"reference":[{"key":"45431_CR1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1212\/WNL.28.3.290","volume":"28","author":"AH Koeppen","year":"1978","unstructured":"Koeppen, A. H. & Barron, K. D. Marchiafava-Bignami disease. Neurology 28, 290\u2013294 (1978).","journal-title":"Neurology"},{"key":"45431_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1552-6569.2007.00202.x","volume":"18","author":"L Aggunlu","year":"2008","unstructured":"Aggunlu, L., Oner, Y., Kocer, B. & Akpek, S. The value of diffusion-weighted imaging in the diagnosis of Marchiafava-Bignami disease: Apropos of a case. J. Neuroimaging. 18, 188\u2013190 (2008).","journal-title":"J. Neuroimaging."},{"key":"45431_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1590\/S0103-507X2013000100013","volume":"25","author":"PE Carrilho","year":"2013","unstructured":"Carrilho, P. E., Santos, M. B., Piasecki, L. & Jorge, A. C. Marchiafava-Bignami disease: A rare entity with a poor outcome. Rev. Bras. Ter. Intensiva. 25, 68\u201372 (2013).","journal-title":"Rev. Bras. Ter. Intensiva."},{"key":"45431_CR4","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s00415-004-0566-1","volume":"251","author":"A Heinrich","year":"2004","unstructured":"Heinrich, A., Runge, U. & Khaw, A. V. Clinicoradiologic subtypes of Marchiafava-Bignami disease. J. Neurol. 251, 1050\u20131059 (2004).","journal-title":"J. Neurol."},{"key":"45431_CR5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrneurol.2011.42","volume":"7","author":"NM Zahr","year":"2011","unstructured":"Zahr, N. M., Kaufman, K. L. & Harper, C. G. Clinical and pathological features of alcohol-related brain damage. Nat. Rev. Neurol. 7, 284\u2013294 (2011).","journal-title":"Nat. Rev. Neurol."},{"key":"45431_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/197140090902200106","volume":"22","author":"M Caulo","year":"2009","unstructured":"Caulo, M. et al. Non-alcoholic partially reversible Marchiafava-Bignami disease: Review and relation with reversible splenial lesions. Neuroradiology 22, 35\u201340 (2009).","journal-title":"Neuroradiology"},{"key":"45431_CR7","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.21873\/invivo.12838","volume":"36","author":"A F\u00f6rster","year":"2022","unstructured":"F\u00f6rster, A. et al. Diffusion restricted lesions in the splenium of the Corpus Callosum. In Vivo 36, 1354\u20131359 (2022).","journal-title":"In Vivo"},{"key":"45431_CR8","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/jnnp-2013-307072","volume":"85","author":"D Renard","year":"2014","unstructured":"Renard, D. et al. An MRI review of acquired corpus callosum lesions. J. Neurol. Neurosurg Psychiatry 85, 1041\u20131048 (2014).","journal-title":"J. Neurol. Neurosurg Psychiatry"},{"key":"45431_CR9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00330-005-0037-9","volume":"16","author":"A Uchino","year":"2006","unstructured":"Uchino, A., Takase, Y., Nomiyama, K., Egashira, R. & Kudo, S. Acquired lesions of the corpus callosum: MR imaging. Eur. Radiol. 16, 905\u2013914 (2006).","journal-title":"Eur. Radiol."},{"key":"45431_CR10","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1097\/CM9.0000000000000334","volume":"132","author":"YY Shen","year":"2019","unstructured":"Shen, Y. Y., Zhou, C. G., Han, N., Liang, X. M. & Deng, Y. Q. Clinical and neuroradiological features of 15 patients diagnosed with Marchiafava-Bignami disease. Chin. Med. J. (Engl) 132, 1887\u20131889 (2019).","journal-title":"Chin. Med. J. (Engl)"},{"key":"45431_CR11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1148\/rg.2017160085","volume":"37","author":"J Starkey","year":"2017","unstructured":"Starkey, J., Kobayashi, N., Numaguchi, Y. & Moritani, T. Cytotoxic lesions of the corpus callosum that show restricted diffusion: mechanisms, causes, and manifestations. Radiographics 37, 562\u2013576 (2017).","journal-title":"Radiographics"},{"key":"45431_CR12","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1177\/0284185120943040","volume":"62","author":"W Li","year":"2021","unstructured":"Li, W., Ran, C. & Ma, J. Diverse MRI findings and clinical outcomes of acute Marchiafava-Bignami disease. Acta Radiol. 62, 904\u2013908 (2021).","journal-title":"Acta Radiol."},{"key":"45431_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1046\/j.1471-4159.2003.01984.x","volume":"87","author":"B Hassel","year":"2003","unstructured":"Hassel, B., Boldingh, K. A., Narvesen, C., Iversen, E. G. & Skrede, K. K. Glutamate transport, glutamine synthetase and phosphateactivated glutaminase in rat CNS white matter: A quantitative study. J. Neurochem. 87, 230\u2013237 (2003).","journal-title":"J. Neurochem."},{"key":"45431_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00234-012-1083-z","volume":"55","author":"A F\u00f6rster","year":"2013","unstructured":"F\u00f6rster, A. et al. Value of diffusion-weighted imaging in central pontine and extrapontine myelinolysis. Neuroradiology 55, 49\u201356 (2013).","journal-title":"Neuroradiology"},{"key":"45431_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000296705","volume":"2","author":"T Yoshizaki","year":"2014","unstructured":"Yoshizaki, T., Hashimoto, T., Fujimoto, K. & Oguchi, K. Evolution of callosal and cortical lesions on MRI in Marchiafava-Bignami disease. Case Rep. Neurol. 2, 19\u201323 (2014).","journal-title":"Case Rep. Neurol."},{"key":"45431_CR16","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3174\/ajnr.A1897","volume":"31","author":"CS Tung","year":"2010","unstructured":"Tung, C. S. et al. Marchiafava-Bignami disease with widespread lesions and complete recovery. Am. J. Neuroradiol. 31, 1506\u20131507 (2010).","journal-title":"Am. J. Neuroradiol."},{"key":"45431_CR17","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.braindev.2013.05.007","volume":"36","author":"M Kashiwagi","year":"2014","unstructured":"Kashiwagi, M. et al. Clinico-radiological spectrum of reversible splenial lesions in children. Brain Dev. 36, 330\u2013336 (2014).","journal-title":"Brain Dev."},{"key":"45431_CR18","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s002340000430","volume":"42","author":"SA Friese","year":"2000","unstructured":"Friese, S. A., Bitzer, M., Freudenstein, D., Voigt, K. & K\u00fcker, W. Classification of acquired lesions of the corpus callosum with MRI. Neuroradiology 42, 795\u2013802 (2000).","journal-title":"Neuroradiology"},{"key":"45431_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ejpn.2015.01.011","volume":"19","author":"A Ka","year":"2015","unstructured":"Ka, A. et al. Mild encephalopathy with reversible splenial lesion: An important differential of encephalitis. Eur. J. Paediatr. Neurol. 19, 377\u2013382 (2015).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"45431_CR20","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1552-6569.2012.00755.x","volume":"24","author":"H Wenz","year":"2014","unstructured":"Wenz, H., Eisele, P., Artemis, D., F\u00f6rster, A. & Brockmann, M. A. Acute Marchiafava-Bignami disease with extensive diffusion restriction and early recovery: Case report and review of the literature. J. Neuroimaging 24, 421\u2013424 (2014).","journal-title":"J. Neuroimaging"},{"key":"45431_CR21","first-page":"156","volume":"40","author":"J Staszewski","year":"2006","unstructured":"Staszewski, J., Macek, K. & Stepien, A. Reversible demyelinisation of corpus callosum in the course of Marchiafava-Bignami disease. Neurol. Neurochir. Pol. 40, 156\u2013161 (2006).","journal-title":"Neurol. Neurochir. Pol."},{"key":"45431_CR22","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.2176\/nmc.50.1118","volume":"50","author":"S Osuka","year":"2010","unstructured":"Osuka, S. et al. Mild encephalitis\/encephalopathy with a reversible splenial lesion: evaluation by diffusion tensor imaging Two case reports. Neurol. Med. Chir. (Tokyo) 50, 1118\u20131122 (2010).","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"45431_CR23","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/j.1552-6569.2008.00279.x","volume":"21","author":"JC Garcia-Monco","year":"2011","unstructured":"Garcia-Monco, J. C. et al. Reversible splenial lesion syndrome (RESLES): What\u2019s in a name?. J. Neuroimaging 21, e1-14 (2011).","journal-title":"J. Neuroimaging"},{"key":"45431_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-016-0572-9","volume":"16","author":"Y Zhu","year":"2016","unstructured":"Zhu, Y. et al. Reversible splenial lesion syndrome associated with encephalitis\/encephalopathy presenting with great clinical heterogeneity. BMC Neurol. 16, 1\u20138 (2016).","journal-title":"BMC Neurol."},{"key":"45431_CR25","first-page":"836","volume":"27","author":"J Takanashi","year":"2006","unstructured":"Takanashi, J. et al. Widening spectrum of a reversible splenial lesion with transiently reduced diffusion. Am. J. Neuroradiol. 27, 836\u2013838 (2006).","journal-title":"Am. J. Neuroradiol."},{"key":"45431_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jns.2010.02.013","volume":"292","author":"J Takanashi","year":"2010","unstructured":"Takanashi, J., Imamura, A., Hayakawa, F. & Terada, H. Differences in the time course of splenial and white matter lesions in clinically mild encephalitis\/encephalopathy with a reversible splenial lesion (MERS). J. Neurol. Sci. 292, 24\u201327 (2010).","journal-title":"J. Neurol. Sci."},{"key":"45431_CR27","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00234-005-1368-6","volume":"47","author":"C Hlaihel","year":"2005","unstructured":"Hlaihel, C. et al. Diffusion weighted magnetic resonance imaging in Marchiafava-Bignami disease: follow-up studies. Neuroradiology 47, 520\u2013524 (2005).","journal-title":"Neuroradiology"},{"key":"45431_CR28","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s13760-017-0876-6","volume":"120","author":"ZE Balcik","year":"2020","unstructured":"Balcik, Z. E. et al. Does restricted diffusion in the splenium indicate an acute infarct?. Acta. Neurol. Belg. 120, 1085\u20131089 (2020).","journal-title":"Acta. Neurol. Belg."},{"key":"45431_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.21873\/invivo.11034","volume":"31","author":"A Nishimoto","year":"2017","unstructured":"Nishimoto, A., Usery, J., Winton, J. C. & Twilla, J. High-dose parenteral thiamine in treatment of Wernicke\u2019s encephalopathy: Case series and review of the literature. In Vivo 31, 121\u2013124 (2017).","journal-title":"In Vivo"},{"key":"45431_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/jnnp-2013-305979","volume":"85","author":"M Hillbom","year":"2014","unstructured":"Hillbom, M. et al. Diagnosis and management of Marchiafava-Bignami disease: A review of CT\/MRI confirmed cases. J. Neurol. Neurosurg Psychiatry 85, 168\u2013173 (2014).","journal-title":"J. Neurol. Neurosurg Psychiatry"},{"key":"45431_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1530-0277.1993.tb00718.x","volume":"17","author":"ME Charness","year":"1993","unstructured":"Charness, M. E. Brain lesions in alcoholics. Alcohol Clin. Exp. Res. 17, 2\u201311 (1993).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"45431_CR32","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ejcn.2016.267","volume":"71","author":"LMP Fernandes","year":"2017","unstructured":"Fernandes, L. M. P. et al. Thiamine deficiency, oxidative metabolic pathways and ethanol-induced neurotoxicity: how poor nutrition contributes to the alcoholic syndrome, as MarchiafavaBignami disease. Eur. J. Clin. Nutr. 71, 580\u2013586 (2017).","journal-title":"Eur. J. Clin. Nutr."},{"key":"45431_CR33","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s00415-003-1072-6","volume":"250","author":"A Gerlach","year":"2003","unstructured":"Gerlach, A. et al. Use of high-dose cortisone in a patient with Marchiafava-Bignami disease. J. Neurol. 250, 758\u2013760 (2003).","journal-title":"J. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45431-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45431-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45431-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T13:04:10Z","timestamp":1698498250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45431-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,28]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["45431"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-45431-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,28]]},"assertion":[{"value":"19 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18516"}}